Dent Neuroscience Research Center Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01813591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

lamotrigine (lamictal) (1 trial)

Drugs in Phase 2 Trials (2)

corticotropin (acthar) (1 trial)

primidone (mysoline) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dizziness (Phase 3)

Meniere Disease (Phase 3)

Migraine Disorders (Phase 2)

Neoplasm Metastasis (Phase 2)

Vertigo (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3